Back

Teitur’s TT-P34 Phase I trial supports Phase II Parkinson’s study in 2027

Verifying
  • Teitur Trophics reported successful Phase I results for TT-P34 in Parkinson’s disease.
  • 67 participants received TT-P34 across healthy-volunteer and early-stage Parkinson’s cohorts.
  • Teitur plans to start a Phase II Parkinson’s trial in 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.